Company Name,award_title,agency,branch,phase,program,agency_tracking_number,contract,proposal_award_date,contract_end_date,solicitation_number,solicitation_year,topic_code,award_year,award_amount,award_link
"Atlas Biologics, LLC",Development of Deep Mutational Scanning with Duplex Sequencing (DMS-DS) for anti-cancer drug evaluation and administration,HHS,NIH,Phase I,STTR,R42CA290940,1R42CA290940-01,2024-06-01,2025-05-31,PA20-272,2020,NCI,2024,455000.0000,213045
